With her employment we are strengthening our sales and marketing function. She will become a key point of communication for existing and new clients.
She will be responsible for securing target sales through developing relationships and industry networks.
Colin Mackay, Symbiosis CEO said “We are delighted to have Joanne joining the Symbiosis team and her strategic appointment is a key element of the companies’ growth plans and her role is central to the development of our commercial operations. Joanne’s energy and experience aligns with the ambitions of the company and strengthens our ability to tailor our services to our clients’ specific sterile manufacturing needs and not the other way around!”
Joanne says “I’ve had a keen interest in Symbiosis since learning of their manufacturing capabilities and unique facility designed and operated to ensure lead times, key milestones and clinical trial deadlines, are met and ideally exceeded”.
“At the heart of any business are the people and as soon as I met the Symbiosis team I could feel the energy in this dynamic and rapidly developing organisation. The Symbiosis focus on the creation of long-term mutually beneficial relationships aligns strongly with my belief of how service providers can integrate seamlessly as a preferred outsourcing partner.” added Joanne.
Symbiosis Pharmaceutical Services specialise in the GMP manufacture of liquid, lyophilized, cytotoxic, conventional and biological pharmaceuticals phase I and phase II clinical trials.